Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative gemcitabine + nab-paclitaxel and IMRT for locally advanced pancreatic cancer
jRCT1031200325Phase 2Recruiting
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gemcitabine and paclitaxel in pancreatic cancer (PC). Primary endpoints: Optimal radiation dose and Transition rate to radical surgical resection. Started Jan 2021; status: recruiting.
02
Drugs
gemcitabinepaclitaxel
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on jRCT1031200325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031200325.